Revenue: The sum of all revenue fields included for a company's operating activities.
PTC Therapeutics, Inc. (PTCT) had Revenue of $806.78M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$806.78M |
$-363.30M |
|
$57.40M |
|
$749.38M |
|
$1.11B |
|
$-302.57M |
|
$-60.55M |
|
$-363.12M |
|
$-363.12M |
|
$-363.30M |
|
$-363.30M |
|
$-363.30M |
|
$-363.30M |
|
$-302.57M |
|
$-78.69M |
|
76.85M |
|
76.85M |
|
$-4.73 |
|
$-4.73 |
|
| Balance Sheet Financials | |
$1.37B |
|
$60.97M |
|
$339.49M |
|
$1.71B |
|
$580.98M |
|
$2.12B |
|
$2.22B |
|
$2.80B |
|
$-1.10B |
|
$-1.30B |
|
$-1.10B |
|
77.70M |
|
| Cash Flow Statement Financials | |
$-107.69M |
|
$44.18M |
|
$255.87M |
|
$610.28M |
|
$795.32M |
|
$185.03M |
|
$74.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.35 |
|
-- |
|
-- |
|
2.07 |
|
-2.17 |
|
92.89% |
|
-37.50% |
|
-37.50% |
|
-9.75% |
|
-45.01% |
|
-45.03% |
|
$-86.13M |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
2.47 |
|
5.09 |
|
71.73 |
|
33.08% |
|
27.96% |
|
-21.31% |
|
-35.38% |
|
$-14.13 |
|
$-1.12 |
|
$-1.40 |
|